Abstract
Introduction/Aims Oral cancer is recognised to be a major public health issue worldwide, with the incidence of the disease increasing over the past few decades. With approximately 4,000 deaths from head and neck cancer in 2016 and a survival rate of 19%-59% for 10 or more years, the importance of effective treatment is key. The British Association of Head and Neck Oncologists (BAHNO) outlined guidance in 2009 for the treatment of patients with head and neck cancer. Surgery is still considered to be one of the main methods of treatment for oncology patients. Therefore obtaining clear surgical margins in head and neck cancer is paramount in the survival of oncology patients.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
